TriSalus Life Sciences (TLSIW) Cash & Current Investments (2022 - 2025)
Historic Cash & Current Investments for TriSalus Life Sciences (TLSIW) over the last 4 years, with Q3 2025 value amounting to $22.7 million.
- TriSalus Life Sciences' Cash & Current Investments rose 10098.33% to $22.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.7 million, marking a year-over-year increase of 10098.33%. This contributed to the annual value of $8.5 million for FY2024, which is 2761.31% down from last year.
- Per TriSalus Life Sciences' latest filing, its Cash & Current Investments stood at $22.7 million for Q3 2025, which was up 10098.33% from $26.5 million recorded in Q2 2025.
- TriSalus Life Sciences' 5-year Cash & Current Investments high stood at $26.5 million for Q2 2025, and its period low was $50930.0 during Q1 2022.
- For the 4-year period, TriSalus Life Sciences' Cash & Current Investments averaged around $9.7 million, with its median value being $9.4 million (2022).
- Within the past 5 years, the most significant YoY rise in TriSalus Life Sciences' Cash & Current Investments was 1575092.57% (2024), while the steepest drop was 4721.04% (2024).
- TriSalus Life Sciences' Cash & Current Investments (Quarter) stood at $9.4 million in 2022, then rose by 25.1% to $11.8 million in 2023, then fell by 27.61% to $8.5 million in 2024, then surged by 166.12% to $22.7 million in 2025.
- Its last three reported values are $22.7 million in Q3 2025, $26.5 million for Q2 2025, and $13.0 million during Q1 2025.